BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11434427)

  • 1. Molecular virology of hepatitis C virus.
    Kato N
    Acta Med Okayama; 2001 Jun; 55(3):133-59. PubMed ID: 11434427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation.
    Kato N
    Microb Comp Genomics; 2000; 5(3):129-51. PubMed ID: 11252351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing and functions of Hepatitis C virus proteins.
    Suzuki R; Suzuki T; Ishii K; Matsuura Y; Miyamura T
    Intervirology; 1999; 42(2-3):145-52. PubMed ID: 10516468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
    Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
    Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells.
    Masalova OV; Lesnova EI; Solyev PN; Zakirova NF; Prassolov VS; Kochetkov SN; Ivanov AV; Kushch AA
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular virology of the hepatitis C virus.
    De Francesco R
    J Hepatol; 1999; 31 Suppl 1():47-53. PubMed ID: 10622560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acid variants in the hepatitis C virus non-structural protein 4A.
    Bermúdez-Aguirre AD; Padilla-Noriega L; Zenteno E; Reyes-Leyva J
    Tohoku J Exp Med; 2009 Jul; 218(3):165-75. PubMed ID: 19561386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus].
    Querenghi F; Zoulim F
    Rev Prat; 2000 May; 50(10):1060-5. PubMed ID: 10905089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonstructural proteins of the hepatitis C virus: structure and functions.
    Neddermann P; Tomei L; Steinkühler C; Gallinari P; Tramontano A; De Francesco R
    Biol Chem; 1997 Jun; 378(6):469-76. PubMed ID: 9224925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing pathways of the hepatitis C virus proteins.
    Lohmann V; Koch JO; Bartenschlager R
    J Hepatol; 1996; 24(2 Suppl):11-9. PubMed ID: 8836884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible Involvement of the NS3 Protein of Hepatitis C Virus in Hepatocarcinogenesis : Its Interaction with the p53 Tumor Suppressor.
    Ishido S; Fujita T; Hotta H
    Methods Mol Med; 2000; 45():37-55. PubMed ID: 21341047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Virology of hepatitis C virus].
    Hofmann H
    Wien Med Wochenschr; 2000; 150(23-24):463-6. PubMed ID: 11205175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatitis C virus (HCV) core protein- induced cell growth by non-structural protein 4A (NS4A) is mediated by mitochondrial dysregulation.
    Selimović D; Hassan M
    Bosn J Basic Med Sci; 2008 Feb; 8(1):4-11. PubMed ID: 18318665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines.
    De Francesco R; Neddermann P; Tomei L; Steinkühler C; Gallinari P; Folgori A
    Semin Liver Dis; 2000; 20(1):69-83. PubMed ID: 10895433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
    Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
    Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase.
    Attwood MR; Bennett JM; Campbell AD; Canning GG; Carr MG; Conway E; Dunsdon RM; Greening JR; Jones PS; Kay PB; Handa BK; Hurst DN; Jennings NS; Jordan S; Keech E; O'Brien MA; Overton HA; King-Underwood J; Raynham TM; Stenson KP; Wilkinson CS; Wilkinson TC; Wilson FX
    Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and identification of hepatitis C virus polyprotein cleavage products.
    Grakoui A; Wychowski C; Lin C; Feinstone SM; Rice CM
    J Virol; 1993 Mar; 67(3):1385-95. PubMed ID: 7679746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus as a causative agent of carcinogenesis--recent trends for study].
    Kato N
    Nihon Rinsho; 1997 Nov; 55(11):3051-62. PubMed ID: 9396312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the molecular biology of hepatitis C virus.
    Rosenberg S
    J Mol Biol; 2001 Oct; 313(3):451-64. PubMed ID: 11676530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C viral RNA: challenges and promises.
    Shi ST; Lai MM
    Cell Mol Life Sci; 2001 Aug; 58(9):1276-95. PubMed ID: 11577984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.